Tuhura Biosciences, INC./NV 8-K Filing
Ticker: HURA · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1498382
Sentiment: neutral
Filing Stats: 858 words · 3 min read · ~3 pages · Grade level 12.6 · Accepted 2025-11-03 16:10:06
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share HURA The Nasdaq
Filing Documents
- d73851d8k.htm (8-K) — 30KB
- d73851dex991.htm (EX-99.1) — 309KB
- d73851dex992.htm (EX-99.2) — 330KB
- d73851dex993.htm (EX-99.3) — 259KB
- g73851g1031220058902.jpg (GRAPHIC) — 24KB
- g73851g1031220059151.jpg (GRAPHIC) — 15KB
- g73851g1031220059277.jpg (GRAPHIC) — 33KB
- g73851g1031220059401.jpg (GRAPHIC) — 10KB
- g73851g1031220059509.jpg (GRAPHIC) — 28KB
- g73851g1031220059650.jpg (GRAPHIC) — 19KB
- g73851g1031220059822.jpg (GRAPHIC) — 23KB
- g73851g1031220100198.jpg (GRAPHIC) — 20KB
- g73851g1031220100386.jpg (GRAPHIC) — 21KB
- 0001193125-25-262562.txt ( ) — 1523KB
- hura-20251103.xsd (EX-101.SCH) — 3KB
- hura-20251103_lab.xml (EX-101.LAB) — 18KB
- hura-20251103_pre.xml (EX-101.PRE) — 11KB
- d73851d8k_htm.xml (XML) — 4KB
Risk Factors
Risk Factors 99.3 Unaudited Pro Forma Condensed Combined Financial Information of TuHURA Biosciences, Inc. as of and for the period ended June 29, 2025 and for the year ended December 31, 2024 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are not guarantees of future performance and that TuHURA's actual results may differ materially from those set forth in the forward-looking statements. All of these forward-looking statements are subject to risks and uncertainties that may change at any time. Factors that could cause TuHURA's actual expectations to differ materially from these forward-looking statements and include the factors under the heading "Risk Factors" set forth in the Form 10-K, as supplemented by TuHURA's quarterly reports on Form 10-Q and current reports on Form 8-K. Such filings are available on our website or at www.sec.gov. You should not place undue reliance on these forward-looking statements, which are made only as of the date hereof. TuHURA undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as may be required under applicable securities laws.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TUHURA BIOSCIENCES, INC. Date: November 3, 2025 By: /s/ Dan Dearborn Name: Dan Dearborn Title: Chief Financial Officer